New York State Common Retirement Fund Genprex, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$2.59 - $3.36 $657 - $853	-254 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.11 - $4.87 $46,793 - $73,274	-15,046 Reduced 98.34%	254 $1,000
Q3 2020 Nov 05, 2020	SELL	$2.9 - $4.29 $39,150 - $57,915	-13,500 Reduced 46.88%	15,300 $51,000
Q2 2020 Aug 07, 2020	BUY	$1.99 - $3.64 $57,312 - $104,832	28,800 New	28,800 $90,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $48.5M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.